Faes Farma SA (FAE) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.048x

Based on the latest financial reports, Faes Farma SA (FAE) has a cash flow conversion efficiency ratio of 0.048x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€35.56 Million ≈ $41.57 Million USD) by net assets (€747.70 Million ≈ $874.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Faes Farma SA to measure how many days the company can operate on defensive assets alone.

Faes Farma SA - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Faes Farma SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Faes Farma SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Faes Farma SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Globant SA F:2G2	0.079x
Grandjoy Holdings Group Co Ltd SHE:000031	-0.023x
Proeduca Altus S.A. MC:PRO	0.577x
Top Glove Corporation Bhd KLSE:7113	0.012x
Monte Rosa Therapeutics Inc NASDAQ:GLUE	-0.072x
Anhui Xinhua Media Co Ltd SHG:601801	-0.035x
Vinati Organics Limited NSE:VINATIORGA	0.122x
Keystone Microtech Corp TWO:6683	0.084x

Annual Cash Flow Conversion Efficiency for Faes Farma SA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Faes Farma SA from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Faes Farma SA worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€747.70 Million ≈ $874.14 Million	€78.49 Million ≈ $91.76 Million	0.105x	-33.94%
2024-12-31	€726.62 Million ≈ $849.49 Million	€115.47 Million ≈ $134.99 Million	0.159x	+4.40%
2023-12-31	€663.35 Million ≈ $775.52 Million	€100.97 Million ≈ $118.04 Million	0.152x	-14.15%
2022-12-31	€602.28 Million ≈ $704.13 Million	€106.79 Million ≈ $124.85 Million	0.177x	+19.78%
2021-12-31	€538.07 Million ≈ $629.06 Million	€79.64 Million ≈ $93.11 Million	0.148x	-10.82%
2020-12-31	€472.88 Million ≈ $552.84 Million	€78.49 Million ≈ $91.76 Million	0.166x	+1.59%
2019-12-31	€413.65 Million ≈ $483.60 Million	€67.58 Million ≈ $79.01 Million	0.163x	-0.83%
2018-12-31	€360.15 Million ≈ $421.06 Million	€59.34 Million ≈ $69.37 Million	0.165x	+26.65%
2017-12-31	€320.77 Million ≈ $375.02 Million	€41.73 Million ≈ $48.78 Million	0.130x	-25.32%
2016-12-31	€284.89 Million ≈ $333.06 Million	€49.62 Million ≈ $58.02 Million	0.174x	+8.29%
2015-12-31	€254.34 Million ≈ $297.34 Million	€40.91 Million ≈ $47.83 Million	0.161x	+14.00%
2014-12-31	€228.63 Million ≈ $267.29 Million	€32.26 Million ≈ $37.71 Million	0.141x	-11.81%
2013-12-31	€197.81 Million ≈ $231.26 Million	€31.65 Million ≈ $37.00 Million	0.160x	+23.86%
2012-12-31	€184.82 Million ≈ $216.07 Million	€23.87 Million ≈ $27.91 Million	0.129x	+8.38%
2011-12-31	€167.61 Million ≈ $195.96 Million	€19.98 Million ≈ $23.35 Million	0.119x	+29.44%
2010-12-31	€165.51 Million ≈ $193.50 Million	€15.24 Million ≈ $17.81 Million	0.092x	-33.21%
2009-12-31	€122.93 Million ≈ $143.71 Million	€16.95 Million ≈ $19.81 Million	0.138x	-37.03%
2008-12-31	€156.71 Million ≈ $183.21 Million	€34.31 Million ≈ $40.11 Million	0.219x	+153.53%
2007-12-31	€151.06 Million ≈ $176.60 Million	€13.04 Million ≈ $15.25 Million	0.086x	-39.41%
2006-12-31	€139.85 Million ≈ $163.50 Million	€19.93 Million ≈ $23.30 Million	0.143x	+40.54%
2005-12-31	€131.62 Million ≈ $153.88 Million	€13.35 Million ≈ $15.60 Million	0.101x	--

About Faes Farma SA

MC:FAE Spain Drug Manufacturers - Specialty & Generic

Market Cap

$1.64 Billion

€1.40 Billion EUR

Market Cap Rank

#7386 Global

#59 in Spain

Share Price

€4.51

Change (1 day)

-0.11%

52-Week Range

€4.13 - €5.38

All Time High

€5.38